Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

EQS-News: Dermapharm Holding SE successfully maintains growth trend as planned
EQS-News: Dermapharm Holding SE successfully maintains growth trend as planned
EQS-News: Dermapharm Holding SE successfully maintains growth trend as planned
eqs_en 
0 16.11.22
DGAP-News: Dermapharm Holding SE publishes H1 2022 financial report, confirms outlook for 2022 overall
DGAP-News: Dermapharm Holding SE publishes H1 2022 financial report, confirms outlook for 2022 overall
DGAP-News: Dermapharm Holding SE publishes H1 2022 financial report, confirms outlook for 2022 overall
eqs_en 
0 07.09.22
DGAP-News: Dermapharm Holding SE: Successful first half of 2022 in challenging market environment
DGAP-News: Dermapharm Holding SE: Successful first half of 2022 in challenging market environment
DGAP-News: Dermapharm Holding SE: Successful first half of 2022 in challenging market environment
eqs_en 
0 23.08.22
DGAP-News: Dermapharm commits to acquire the French market leader for herbal medicinal products and food supplements
DGAP-News: Dermapharm commits to acquire the French market leader for herbal medicinal products and food supplements
DGAP-News: Dermapharm commits to acquire the French market leader for herbal medicinal products and food supplements
eqs_en 
0 30.07.22
DGAP-Adhoc: Dermapharm Holding SE: binding offer to acquire Arkopharma Group
DGAP-Adhoc: Dermapharm Holding SE: binding offer to acquire Arkopharma Group
DGAP-Adhoc: Dermapharm Holding SE: binding offer to acquire Arkopharma Group
eqs_en 
0 30.07.22
DGAP-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 2.17 per share
DGAP-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 2.17 per share
DGAP-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 2.17 per share
eqs_en 
0 01.06.22
DGAP-News: Dermapharm Holding SE: excellent start into financial year 2022
DGAP-News: Dermapharm Holding SE: excellent start into financial year 2022
DGAP-News: Dermapharm Holding SE: excellent start into financial year 2022
eqs_en 
0 18.05.22
DGAP-News: Dermapharm Holding SE: 2021 erfolgreichstes Jahr der Firmengeschichte - kontinuierliches Wachstum im Geschäftsjahr 2022
DGAP-News: Dermapharm Holding SE: 2021 erfolgreichstes Jahr der Firmengeschichte - kontinuierliches Wachstum im Geschäftsjahr 2022
DGAP-News: Dermapharm Holding SE: 2021 erfolgreichstes Jahr der Firmengeschichte - kontinuierliches Wachstum im Geschäftsjahr 2022
eqs_de 
0 12.04.22
DGAP-News: Dermapharm Holding SE records best ever year in 2021 - continuous growth in financial year 2022
DGAP-News: Dermapharm Holding SE records best ever year in 2021 - continuous growth in financial year 2022
DGAP-News: Dermapharm Holding SE records best ever year in 2021 - continuous growth in financial year 2022
eqs_en 
0 12.04.22
DGAP-News: Dermapharm Holding SE: Continuous growth of Group revenues and adjusted Group EBITDA in 2022
DGAP-News: Dermapharm Holding SE: Continuous growth of Group revenues and adjusted Group EBITDA in 2022
DGAP-News: Dermapharm Holding SE: Continuous growth of Group revenues and adjusted Group EBITDA in 2022
eqs_en 
0 29.03.22
DGAP-News: Dermapharm Holding SE: Kontinuierliches Wachstum von Konzernumsatz und bereinigtem Konzern-EBITDA in 2022
DGAP-News: Dermapharm Holding SE: Kontinuierliches Wachstum von Konzernumsatz und bereinigtem Konzern-EBITDA in 2022
DGAP-News: Dermapharm Holding SE: Kontinuierliches Wachstum von Konzernumsatz und bereinigtem Konzern-EBITDA in 2022
eqs_de 
0 29.03.22
DGAP-News: Dermapharm Holding SE: Most successful business year in the company's history - Adjusted Group EBITDA at the upper end of the outlook
DGAP-News: Dermapharm Holding SE: Most successful business year in the company's history - Adjusted Group EBITDA at the upper end of the outlook
DGAP-News: Dermapharm Holding SE: Most successful business year in the company's history - Adjusted Group EBITDA at the upper end of the outlook
eqs_en 
0 22.03.22
DGAP-News: Dermapharm Holding SE: Erfolgreichstes Geschäftsjahr der Firmengeschichte - bereinigtes Konzern-EBITDA am oberen Ende der Prognose
DGAP-News: Dermapharm Holding SE: Erfolgreichstes Geschäftsjahr der Firmengeschichte - bereinigtes Konzern-EBITDA am oberen Ende der Prognose
DGAP-News: Dermapharm Holding SE: Erfolgreichstes Geschäftsjahr der Firmengeschichte - bereinigtes Konzern-EBITDA am oberen Ende der Prognose
eqs_de 
0 22.03.22
DGAP-News: Dermapharm successfully acquires C³ Group
DGAP-News: Dermapharm successfully acquires C³ Group
DGAP-News: Dermapharm successfully acquires C³ Group
eqs_en 
0 31.01.22
DGAP-News: Dermapharm akquiriert erfolgreich C³-Gruppe
DGAP-News: Dermapharm akquiriert erfolgreich C³-Gruppe
DGAP-News: Dermapharm akquiriert erfolgreich C³-Gruppe
eqs_de 
0 31.01.22
DGAP-News: Dermapharm Holding SE raises EBITDA forecast for the full year 2021
DGAP-News: Dermapharm Holding SE raises EBITDA forecast for the full year 2021
DGAP-News: Dermapharm Holding SE raises EBITDA forecast for the full year 2021
eqs_en 
0 16.12.21
DGAP-News: Dermapharm Holding SE erhöht EBITDA-Prognose für das Gesamtjahr 2021
DGAP-News: Dermapharm Holding SE erhöht EBITDA-Prognose für das Gesamtjahr 2021
DGAP-News: Dermapharm Holding SE erhöht EBITDA-Prognose für das Gesamtjahr 2021
eqs_de 
0 16.12.21
DGAP-Adhoc: Dermapharm Holding SE hebt EBITDA-Prognose für das Gesamtjahr 2021 an
DGAP-Adhoc: Dermapharm Holding SE hebt EBITDA-Prognose für das Gesamtjahr 2021 an
DGAP-Adhoc: Dermapharm Holding SE hebt EBITDA-Prognose für das Gesamtjahr 2021 an
eqs_de 
0 16.12.21
DGAP-News: Dermapharm Holding SE übernimmt C³-Gruppe und baut ihre Aktivitäten im Cannabis-Markt aus
DGAP-News: Dermapharm Holding SE übernimmt C³-Gruppe und baut ihre Aktivitäten im Cannabis-Markt aus
DGAP-News: Dermapharm Holding SE übernimmt C³-Gruppe und baut ihre Aktivitäten im Cannabis-Markt aus
eqs_de 
0 15.12.21
DGAP-News: Dermapharm Holding SE acquires C³-Group and expands its activities in the cannabis market
DGAP-News: Dermapharm Holding SE acquires C³-Group and expands its activities in the cannabis market
DGAP-News: Dermapharm Holding SE acquires C³-Group and expands its activities in the cannabis market
eqs_en 
0 15.12.21
DGAP-Adhoc: Dermapharm Holding SE: Übernahme der C³ Cannabinoid Compound Company GmbH
DGAP-Adhoc: Dermapharm Holding SE: Übernahme der C³ Cannabinoid Compound Company GmbH
DGAP-Adhoc: Dermapharm Holding SE: Übernahme der C³ Cannabinoid Compound Company GmbH
eqs_de 
0 15.12.21
DGAP-Adhoc: Dermapharm Holding SE: Acquisition of C³ Cannabinoid Compound Company GmbH
DGAP-Adhoc: Dermapharm Holding SE: Acquisition of C³ Cannabinoid Compound Company GmbH
DGAP-Adhoc: Dermapharm Holding SE: Acquisition of C³ Cannabinoid Compound Company GmbH
eqs_en 
0 15.12.21